Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT02629588 Completed - Brain Injuries Clinical Trials

Effectiveness of Sensory Stimulation for Person in a Coma or Persistent Vegetative State After Traumatic Brain Injury

Start date: January 2015
Phase: N/A
Study type: Observational

Appraised the empirical evidence of effectiveness of sensory stimulation to improve arousal and alertness for persons in a coma or persistent vegetative state after traumatic brain injury (TBI). Databases were searched and nine articles met inclusion criteria.

NCT ID: NCT02625896 Completed - Pain Clinical Trials

Free Fall Acrobatics to Reduce Neck Loads During Parachute Opening Shock: Evaluation of an Intervention.

ACROPOSE
Start date: June 17, 2017
Phase: N/A
Study type: Interventional

This study aims to evaluate the use of an aerial human body manoeuvre to reduce the biomechanical load on the neck of a parachutist during the parachute opening, in order to create a basis for future prevention of skydiver neck pain in the parachutist population.

NCT ID: NCT02623218 Completed - Clinical trials for Traumatic Brain Injury

Translational Research Examining Acupuncture Treatment in Traumatic Brain Injury

TREAT-TBI
Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of acupuncture on cerebral blood flow (CBF) and blood biomarkers during the acute 10-day window following traumatic brain injury, to determine if those changes correlate with changes in biomarkers of brain health, neuropsychological testing, and symptomatic presentation.

NCT ID: NCT02622295 Completed - Clinical trials for Spinal Cord Injuries

Musculoskeletal Plasticity After Spinal Cord Injury

Start date: May 2015
Phase: N/A
Study type: Interventional

Patients with spinal cord injury (SCI) experience metabolic syndrome, diabetes, obesity, pressure ulcers, and cardiovascular disease at far greater rates than the general population. A rehabilitation method to prevent or reverse the systemic metabolic consequences of SCI is a pressing need. The purpose of this study is to determine the dose of muscle activity that can enhance an oxidative muscle phenotype and improve clinical markers of metabolic health and bone turnover in patients with SCI. The long-term goal of this research is to develop exercise-based interventions to prevent secondary health conditions such as diabetes and to ultimately protect health-related quality of life (QOL). Specific Aim 1: To compare changes in skeletal muscle gene regulation in individuals who receive high frequency (HF) active-resisted stance and low frequency (LF) active-resisted stance for 3 years. Hypothesis 1: The expression of genes regulating skeletal muscle metabolism will support that HF and LF both instigate a shift toward an oxidative muscle phenotype. A novel finding will be that LF is a powerful regulator of oxidative pathways in skeletal muscle. Specific Aim 2: To compare changes in systemic markers of metabolic health and bone turnover in individuals with SCI who receive HF or LF for 3 years. Hypothesis 2: HF and LF will both reduce glucose/insulin levels and HOMA (homeostasis model assessment) score. Secondary Aim: To measure subject-reported QOL using the EQ-5D survey metric. Hypothesis 3: HF and LF subjects will show a trend toward improved self-reported QOL after 3 years. There will be an association between metabolic improvement and improved perception of QOL. These observations will support that this intervention has strong feasibility for future clinical translation.

NCT ID: NCT02620787 Completed - Diabetes Clinical Trials

Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Start date: February 23, 2016
Phase: Phase 1
Study type: Interventional

This study will determine the tissue penetration of tedizolid (Sivextro, Merck & Co.), a novel oxazolidinone antibiotic, into the extracellular, interstitial fluid of soft tissue in diabetic patients with lower limb wound infections. Penetration will be compared with a group of healthy volunteer control participants.

NCT ID: NCT02619851 Completed - Burn Injury Clinical Trials

A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects

Start date: December 23, 2015
Phase: Phase 2
Study type: Interventional

This clinical trial is a Phase II controlled, parallel, open-label trial, designed to test the efficacy and safety of ALLO-ASC-DFU and conventional therapy in Deep Second-degree burn wound subjects.

NCT ID: NCT02619539 Completed - Trauma, Multiple Clinical Trials

Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)

SIDE
Start date: January 2016
Phase: N/A
Study type: Observational [Patient Registry]

Shock-index is potentially an easy tool to estimate the risk of hypofibrinogenemia without the need to perform other potentially time consuming investigations.

NCT ID: NCT02618226 Completed - Clinical trials for Traumatic Brain Injury

Optic Nerve Ultrasound in Severe Traumatic Injury

ONUS-TBI
Start date: January 2016
Phase:
Study type: Observational

Prospective study of diagnostic accuracy of optic nerve sheath diameter measurement (index study) in traumatic brain injury with simultaneous invasive intracranial pressure monitoring as the reference standard.

NCT ID: NCT02616081 Completed - Quality of Life Clinical Trials

Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury

NBRG-PCORI
Start date: January 1, 2016
Phase:
Study type: Observational

The investigators goal is to create a better understanding of patient reported outcomes for bladder management strategies (clean intermittent catheterization (CIC), indwelling catheter (IDC) and bladder surgery.

NCT ID: NCT02615535 Completed - Clinical trials for Traumatic Brain Injury

Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury

Start date: December 2015
Phase: N/A
Study type: Interventional

Spaulding Rehabilitation Hospital is conducting a research study evaluating the effectiveness of the brain-training product, MUSE, an EEG-guided neurofeedback device designed to assist in cultivating a relaxed, attentive state of mind during meditation. The investigators study aims to evaluate whether such a tool could be useful in treating persistent traumatic brain injury symptoms such as inattention, impulsivity, irritability, or dysregulated mood.